ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 032,27
0,49%
Dow Jones
38 686,32
1,51%
DAX
18 663,80
0,98%
Brent Oil
81,28
0,59%
Bitcoin
69 023,17
1,88%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AMAG Pharmaceuticals Inc (AMAG)

  7. AMAG Pharmaceuticals Inc (AMAG) Actualités

AMAG

AMAG Pharmaceuticals (AMAG)

AMAG Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMAG
DateHeureSourceTitreSymboleSociété
16/02/202122h39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
14/12/202014h47GlobeNewswire Inc.AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing...NASDAQ:AMAGAMAG Pharmaceuticals Inc
27/11/202015h09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AMAGAMAG Pharmaceuticals Inc
24/11/202012h05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AMAGAMAG Pharmaceuticals Inc
24/11/202012h01Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:AMAGAMAG Pharmaceuticals Inc
17/11/202021h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMAGAMAG Pharmaceuticals Inc
17/11/202012h00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202022h40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202022h30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202015h27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202015h25PR Newswire (US)Covis Group Completes Acquisition of AMAG PharmaceuticalsNASDAQ:AMAGAMAG Pharmaceuticals Inc
13/11/202014h30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
06/11/202022h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMAGAMAG Pharmaceuticals Inc
06/11/202000h40PR Newswire (US)MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCa...NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202014h44Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202013h30PR Newswire (Canada)Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202013h23Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:AMAGAMAG Pharmaceuticals Inc
14/10/202022h11GlobeNewswire Inc.AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for...NASDAQ:AMAGAMAG Pharmaceuticals Inc
13/10/202022h37Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:AMAGAMAG Pharmaceuticals Inc
06/10/202003h05GlobeNewswire Inc.AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)NASDAQ:AMAGAMAG Pharmaceuticals Inc
02/10/202019h02PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of AMAG Pharmaceuticals, Inc.NASDAQ:AMAGAMAG Pharmaceuticals Inc
01/10/202023h21Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:AMAGAMAG Pharmaceuticals Inc
01/10/202016h45GlobeNewswire Inc.Covis Group Announces Agreement to Acquire AMAG PharmaceuticalsNASDAQ:AMAGAMAG Pharmaceuticals Inc
15/09/202023h17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/09/202022h07Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
09/09/202014h00GlobeNewswire Inc.AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment ConferenceNASDAQ:AMAGAMAG Pharmaceuticals Inc
06/08/202013h00GlobeNewswire Inc.AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:AMAGAMAG Pharmaceuticals Inc
28/07/202014h00GlobeNewswire Inc.AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 202...NASDAQ:AMAGAMAG Pharmaceuticals Inc
27/07/202013h30GlobeNewswire Inc.AMAG Pharmaceuticals Completes Divestment of Women’s Health AssetsNASDAQ:AMAGAMAG Pharmaceuticals Inc
23/07/202015h01PR Newswire (US)AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Austr...NASDAQ:AMAGAMAG Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AMAG

Dernières Valeurs Consultées

TSXV
ZTE
Ztest Electronics Inc.
USOTC
WBRE
Wild Brush Energy (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés